Skip to content

Clinical trials

Phase 1 Neoplasm Metastasis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 1 Country / region: United States Clear all

697 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20016
20023
20036
200415
200513
200622
200720
200821
200924
201026
201134
201229
201330
201427
201521
201635
201730
201821
201928
202037
202141
202236
202341
202439
202539
202619

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed354
Terminated133
Recruiting116
Active, not recruiting50
Unknown status16
Withdrawn15
Suspended7
Not yet recruiting5
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)68
M.D. Anderson Cancer Center37
Eli Lilly and Company31
Memorial Sloan Kettering Cancer Center17
Pfizer16
H. Lee Moffitt Cancer Center and Research Institute14
Novartis Pharmaceuticals9
City of Hope Medical Center8
University of Chicago6
Akamis Bio5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis697
Neoplasms176
Carcinoma, Non-Small-Cell Lung113
Breast Neoplasms102
Colorectal Neoplasms94
Melanoma85
Lung Neoplasms65
Pancreatic Neoplasms61
Ovarian Neoplasms58
Prostatic Neoplasms52

Trials

Showing 1 to 25 of 697. Each trial links to its page on Pharma Observatory.

597 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.